Soleus Capital Management »

Kodiak Sciences shares owned by Soleus Capital Management

Quarter-by-quarter ownership of Kodiak Sciences (KOD) shares owned by Soleus Capital Management from 13F filings

Historical chart of Soleus Capital Management investment in Kodiak Sciences

Tip: Access up to 7 years of quarterly data

All positions including Kodiak Sciences held by Soleus Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Kodiak Sciences by Soleus Capital Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $322k 20k 16.37

More positions owned by Soleus Capital Management

Krystal Biotech (KRYS)
Tg Therapeutics (TGTX)
Novocure Ord Shs (NVCR)
Spdr Series Trust S&p Biotech Put Option (XBI)
Anthem (ELV)
Beta Bionics (BBNX)
United Therapeutics Corporation (UTHR)
Terns Pharmaceuticals (TERN)
Celcuity (CELC)
Inspire Med Sys (INSP)
Twist Bioscience Corp (TWST)
Argenx Se Sponsored Adr (ARGX)
Organogenesis Hldgs (ORGO)
BioMarin Pharmaceutical (BMRN)
Cidara Therapeutics Com New (CDTX)

View all positions for Soleus Capital Management

Top funds holding Kodiak Sciences

Baker Bros. Advisors
BlackRock
Point72 Asset Management
Vanguard Group
Adage Capital Partners GP
ICONIQ Capital
TCG Crossover Management
Silverarc Capital Management
Acadian Asset Management
State Street Corporation
Geode Capital Management
Boxer Capital Management
Boone Capital Management
Board of Trustees of The Leland Stanford Junior University
Perceptive Advisors

View all funds holding Kodiak Sciences